Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator

Blood

Volumn 101, Issue 12, 2003, Pages 4717-4724

  Ramezani, Ali ^b   Hawley, Teresa S ^b   Hawley, Robert G ^a  

^a HOLLAND LABORATORY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN 5' DEOXYRIBONUCLEOTIDASE 1 HYPERSENSITIVE SITE 4; BETA GLOBULIN; BETA INTERFERON; CD34 ANTIGEN; DEOXYRIBONUCLEOTIDE; HUMAN INTERFERON; HUMAN INTERFERON BETA SCAFFOLD ATTACHMENT REGION; UNCLASSIFIED DRUG; VIRUS VECTOR;

ARTICLE; BLOOD CELL; CELL DIFFERENTIATION; CELL LINE; CELL POPULATION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG EFFICACY; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; LENTIVIRINAE; MOLECULAR CLONING; MONOCYTE; OBSERVATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; STEM CELL; UMBILICAL CORD BLOOD; VIRUS CULTURE;

EID: 0038792207     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-09-2991     Document Type: Article

References (61)

1. Sorrentino BP, Nienhuis AW. The hematopoietic system as a target for gene therapy. In: Friedmann T, ed. The Development of Human Gene Therapy. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1999:351-426.
2. Hawley RG, Sobieski DA. Of mice and men: the tale of two therapies. Stem Cells. 2002;20:275-278.
3. Hawley RG. Progress toward vector design for hematopoietic stem cell gene therapy. Curr Gene Ther. 2001;1:1-17.
4. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol. 1990;10:4239-4242.
5. Lewis PF, Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol. 1994;68:510-516.
6. Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272:263-267.
7. Miyoshi H, Smith KA, Mosier DE, Verma IM, Torbett BE. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science. 1999;283:682-686.
8. Woods N-B, Fahlman C, Mikkola H, et al. Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells. Blood. 2000;96:3725-3733.
9. Guenechea G, Gan OI, Inamitsu T, et al. Transduction of human CD34+CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors. Mol Ther. 2000;1:566-573.
10. Ailles L, Schmidt M, Santoni de Sio FR, et al. Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multipotent, long-term NOD/SCID repopulating hematopoietic cells. Mol Ther. 2002;6:615-626.
11. Woods NB, Muessig A, Schmidt M, et al. Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis. Blood. 2003;101:1284-1289.
12. Imren S, Payen E, Westerman KA, et al. Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells. Proc Natl Acad Sci U S A. 2002;99:14380-14385.
13. Persons DA, Hargrove PW, Allay ER, Hanawa H, Nienhuis AW. The degree of phenotypic correction of murine β-thalassemia intermedia following lentiviral-mediated transfer of a human γ-globin gene is influenced by chromosomal position effects and vector copy number. Blood. 2003;101:2175-2183.
14. Ramezani A, Hawley TS, Hawley RG. Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol Ther. 2000;2:458-469.
15. May C, Rivella S, Callegari J, et al. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human β-globin. Nature. 2000;406:82-86.
16. Pawliuk R, Westerman KA, Fabry ME, et al. Correction of sickle cell disease in transgenic mouse models by gene therapy. Science. 2001;294:2368-2371.
17. Moreau-Gaudry F, Xia P, Jiang G, et al. High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors. Blood. 2001;98:2664-2672.
18. Cui Y, Golob J, Kelleher E, Ye Z, Pardoll D, Cheng L. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells. Blood. 2002;99:399-408.
19. Rivella S, Sadelain M. Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing. Semin Hematol. 1998;35:112-125.
20. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science. 2002;295:868-872.
21. Rivella S, Callegari JA, May C, Tan CW, Sadelain M. The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites. J Virol. 2000;74:4679-4687.
22. Emery DW, Yannaki E, Tubb J, Stamatoyannopoulos G. A chromatin insulator protects retrovirus vectors from chromosomal position effects. Proc Natl Acad Sci U S A. 2000;97:9150-9155.
23. Yannaki E, Tubb J, Aker M, Stamatoyannopoulos G, Emery DW. Topological constraints governing the use of the chicken HS4 chromatin insulator in oncoretrovirus vectors. Mol Ther. 2002;5:589-598.
24. Gerasimova TI, Corces VG. Chromatin insulators and boundaries: effects on transcription and nuclear organization. Annu Rev Genet. 2001;35:193-208.
25. Chung JH, Whiteley M, Felsenfeld G. A 5′ element of the chicken β-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell. 1993;74:505-514.
26. Chung JH, Bell AC, Felsenfeld G. Characterization of the chicken β-globin insulator. Proc Natl Acad Sci U S A. 1997;94:575-580.
27. Bell AC, West AG, Felsenfeld G. The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell. 1999;98:387-396.
28. Litt MD, Simpson M, Gaszner M, Allis CD, Felsenfeld G. Correlation between histone lysine methylation and developmental changes at the chicken β-globin locus. Science. 2001;293:2453-2455.
29. Recillas-Targa F, Pikaart MJ, Burgess-Beusse B, et al. Position-effect protection and enhancer blocking by the chicken β-globin insulator are separable activities. Proc Natl Acad Sci U S A. 2002;99:6883-6888.
30. Burgess-Beusse B, Farrell C, Gaszner M, et al. The insulation of genes from external enhancers and silencing chromatin. Proc Nall Acad Sci U S A. 2002;99(suppl 4):16433-16437.
31. Garrard WT. Chromosomal loop organization in eukaryotic genomes. In: Eckstein F, Lilley DMJ, eds. Nucleic Acids and Molecular Biology. Berlin, Germany: Springer-Verlag; 1990:163-175.
32. Bode J, Maass K. Chromatin domain surrounding the human interferon-β gene as defined by scaffold-attached regions. Biochemistry. 1988;27:4706-4711.
33. Bode J, Kohwi Y, Dickinson L, et al. Biological significance of unwinding capability of nuclear matrix-associating DNAs. Science. 1992;255:195-197.
34. Boulikas T. Nature of DNA sequences at the attachment regions of genes to nuclear matrix. J Cell Biochem. 1993;52:14-22.
35. Namciu SJ, Blochlinger KB, Fournier RE. Human matrix attachment regions insulate transgene expression from chromosomal position effects in Drosophila melanogaster. Mol Cell Biol. 1998;18:2382-2391.
36. Schubeler D, Mielke C, Maass K, Bode J. Scaffold/mattrix-attached regions act upon transcription in a context-dependent manner. Biochemistry. 1996;35:11160-11169.
37. Agarwal M, Austin TW, Morel F, Chen J, Bohnlein E, Plavec I. Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells. J Virol. 1998;72:3720-3728.
38. Auten J, Agarwal M, Chen J, Sutton R, Plavec I. Effect of scaffold attachment region on transgene expression in retrovirus vector-transduced primary T cells and macrophages. Hum Gene Ther. 1999;10:1389-1399.
39. Dang Q, Auten J, Plavec I. Human beta interferon scaffold attachment region inhibits de novo methylation and confers long-term, copy number-dependent expression to a retroviral vector. J Virol. 2000;74:2671-2678.
40. Bode J, Benham C, Knopp A, Mielke C. Transcriptional augmentation: modulation of gene expression by scaffold/matrix-attached regions (S/MAR elements). Crit Rev Eukaryot Gene Expr. 2000;10:73-90.
41. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell. 2000;101:173-185.
42. Cheng L, Du C, Murray D, et al. A GFP reporter system to assess gene transfer and expression in viable human hematopoietic progenitors. Gene Ther. 1997;4:1013-1022.
43. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol. 1987;7:379-387.
44. Rasheed S, Nelson-Rees WA, Toth EM, Arnstein P, Gardner MB. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer. 1974;33:1027-1033.
45. RamezaniA, Hawley RG. Human immunodeficiency virus type 1-based vectors for gene delivery to human hematopoietic stem cells. Methods Mol Med. 2003;76:467-492.
46. Koeffler HP, Billing R, Lusis AJ, Sparkes R, Golde DW. An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood. 1980;56:265-273.
47. Flanagan JR, Krieg AM, Max EE, Khan AS. Negative control region at the 5′ end of murine leukemia virus long terminal repeats. Mol Cell Biol. 1989;9:739-746.
48. Kumar M, Keller B, Makalou N, Sutton RE. Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther. 2001;12:1893-1905.
49. Indraccolo S, Minuzzo S, Roccaforte F, et al. Effects of CD2 locus control region sequences on gene expression by retroviral and lentivirat vectors. Blood. 2001;98:3607-3617.
50. Lu M, Zhang N, Maruyama M, Hawley RG, Ho AD. Retrovirus-mediated gene expression in hematopoietic cells correlates inversely with growth factor stimulation. Hum Gene Ther. 1996;7:2263-2271.
51. Nabirochkin S, Ossokina M, Heidmann T. A nuclear matrix/scaffold attachment region colocalizes with the gypsy retrotransposon insulator sequence. J Biol Chem. 1998;273:2473-2479.
52. Antes TJ, Namciu SJ, Fournier REK, Levy-Wilson B. The 5′ boundary of the human apolipoprotein B chromatin domain in intestinal cells. Biochemistry. 2001;40:6731-6742.
53. Thanos D, Maniatis T. The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene. Cell. 1992;71:777-789.
54. Zhao K, Kas E, Gonzalez E, Laemmli UK. SAR-dependent mobilization of histone H1 by HMG-I/Y in vitro: HMG-I/Y is enriched in H1-depleted chromatin. EMBO J. 1993;12:3237-3247.
55. Miller MD, Bushman FD. HIV integration: Inil for integration? Curr Biol. 1995;5:368-370.
56. Weidhaas JB, Angelichio EL, Fenner S, Coffin JM. Relationship between retroviral DNA integration and gene expression. J Virol. 2000;74:8382-8389.
57. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 2002;110:521-529.
58. Jordan A, Defechereux P, Verdin E. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 2001;20:1726-1738.
59. Ramezani A, Hawley TS, Hawley RG. HIV-based HUMV lentiviral vectors for protection against position effect variegation and transgene silencing [abstract]. Mol Ther. 2001;3:S127.
60. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2003;348:255-256.
61. Marshall E. Gene therapy. Second child in French trial is found to have leukemia. Science. 2003;299:320.